FDA Case-By-Case Approach To Class I Exempt SUDs Needs Change - MDMA

FDA should articulate a policy on reprocessing Class I 510(k)-exempt single-use devices rather than taking action only when problems with a particular product are brought to the agency's attention, according to the Medical Device Manufacturers Association.